Back to top

earnings-esp: Archive

Zacks Equity Research

AeroVironment (AVAV) Earnings Expected to Grow: What to Know Ahead of Q3 Release

AeroVironment (AVAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AVAVNegative Net Change

Zacks Equity Research

TXO Partners LP (TXO) Expected to Beat Earnings Estimates: Should You Buy?

TXO Partners LP (TXO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TXONo Net Change

Zacks Equity Research

Analysts Estimate Target (TGT) to Report a Decline in Earnings: What to Look Out for

Target (TGT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TGTNegative Net Change

Zacks Equity Research

NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

NeuroPace (NPCE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NPCENegative Net Change TFXPositive Net Change

Zacks Equity Research

Analysts Estimate EVgo Inc. (EVGO) to Report a Decline in Earnings: What to Look Out for

EVgo (EVGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EVGONegative Net Change

Zacks Equity Research

Esperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy?

Esperion Therapeutics (ESPR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ESPRNegative Net Change HROWPositive Net Change

Zacks Equity Research

Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Evolus (EOLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EOLSNegative Net Change PRGONegative Net Change

Zacks Equity Research

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?

Rigel (RIGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RIGLNegative Net Change COLLNegative Net Change

Zacks Equity Research

How to Find Strong Consumer Discretionary Stocks Slated for Positive Earnings Surprises

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

LULUNegative Net Change LVSPositive Net Change

Zacks Equity Research

Want Better Returns? Don't Ignore These 2 Retail and Wholesale Stocks Set to Beat Earnings

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

TJXPositive Net Change WSMNegative Net Change